Grant Number Title Description Expires
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01)

The purpose of this funding opportunity announcement (FOA) is to support clinical studies that will fill gaps in the design of upcoming clinical trials in rare neurological or neuromuscular diseases by validating clinical outcome measures or biomarkers, or by characterizing cohorts of relevant patients.  This is the Forms change reissue of PAR 16-020 and has replace PAR 16-020

08/18/2018
Disability and Rehabilitation Research Projects (DRRP) Program: Health and Function (Research)

This particular DRRP opportunity is for an investigator-initiated project.  Applicants must decide whether to submit their proposed work as a research proposal or a development proposal.  The definitions of research and development are provided in each funding opportunity announcement (FOA). Here is how we describe research and development projects in the FOAs: 
 

Research: A grantee must identify one or more hypotheses or research questions and, based on the hypotheses or research questions identified, perform an intensive, systematic study directed toward producing (1) new or full scientific knowledge or (2) understanding of the subject or problem studied.

 

Development: A grantee must use knowledge and understanding gained from research to create models, methods, tools, applications, and devices beneficial to the target population, including design and development of prototypes and processes. 

04/23/2018
Disability and Rehabilitation Research Projects (DRRP) Program: Health and Function (Development)

This particular DRRP opportunity is for an investigator-initiated project.  Applicants must decide whether to submit their proposed work as a research proposal or a development proposal.  The definitions of research and development are provided in each funding opportunity announcement (FOA). Here is how we describe research and development projects in the FOAs: 
 

Research: A grantee must identify one or more hypotheses or research questions and, based on the hypotheses or research questions identified, perform an intensive, systematic study directed toward producing (1) new or full scientific knowledge or (2) understanding of the subject or problem studied.

 

Development: A grantee must use knowledge and understanding gained from research to create models, methods, tools, applications, and devices beneficial to the target population, including design and development of prototypes and processes. 

04/23/2018
Grant Number Title Description Expires
Cooperative Program in Translational Research for Neuromuscular Disease (U01)

Funding for full-scale single component research projects directed at developing new therapies for any neuromuscular disease.

07/03/2011
Exploratory/Developmental Projects in Translational Research for Neuromuscular Disease (R21)

Funding for pilot projects to generate tools and proof-of-principle for therapeutics development in any neuromuscular disease.

09/08/2011
Nuclear Structure-Function Defect in the Pathogenesis of Muscular Dystrophy (R21)

This initiative supports applications focused upon determination of the mechanisms of a subset of muscular dystrophies that may have their basis in nucleus structure-function defects. Applications are specifically solicited for studies of Emery-Dreifuss, facioscapulohumeral, limb girdle muscular dystrophy 1B, and oculopharyngeal muscular dystrophies.

09/21/2009
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50)

The purpose of this Funding Opportunity Announcement (FOA) is to publicize a competition for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational and clinical research and provide important resources that can be used by the national muscular dystrophy research communities. The Centers also provide an outstanding environment for the training of new scientists electing to pursue careers conducting research in high priority areas of muscular dystrophy. Center investigators are expected to participate in important community outreach efforts to increase awareness and convey the importance and implications of their research activities to the patient and advocacy communities.

10/20/2017
Advanced Rehabilitation Research Training (ARRT) grant

HHS-2018-ACL-NIDILRR-ARCP-0240
Advanced Rehabilitation Research Training (ARRT) Program - Community Living and Participation
Department of Health and Human Services
Administration for Community Living

01/16/2018

Information for Researchers

Muscular Dystrophy Research Support from MDCC Member Organizations

2017 Supported Projects
Excel Format 132.0 KB
 

2016 Supported Projects
Excel Format 135.84 KB
 

2015 Supported Projects
PDF Format 1013.26 KB | Excel Format 112.87 KB